MENU

Direct Evidence of the Presence of Cross-Linked A beta Dimers in the Brains of Alzheimer's Disease Patients

de la Torre, AV; Gay, M; Vilaprinyo-Pascual, S; Mazzucato, R; Serra-Batiste, M; Vilaseca, M; Carulla, N

ANALYTICAL CHEMISTRY
2018
VL / 90 - BP / 4552 - EP / 4560
abstract
Brain-derived amyloid-beta (A beta) dimers are associated with Alzheimer's disease (AD). However, their covalent nature remains controversial. This feature is relevant, as a covalent cross-link has been proposed to make brain-derived dimers (brain dimers) more synaptotoxic than A beta monomers and would also make them suitable candidates for biomarker development. To resolve this controversy, we here present a three-step approach. First, we validated a type of synthetic cross-linked A beta (CL A beta) dimers, obtained by means of the photoinduced cross-linking of unmodified proteins (PICUP) reaction, as well-defined mimics of putative brain CL A beta dimers. Second, we used these PICUP CL A beta dimers as standards to improve the isolation of brain A beta dimers and to develop state-of-the-art mass spectrometry (MS) strategies to allow their characterization. Third, we applied these MS methods to the analysis of brain A beta dimer samples allowing the detection of the CL [A beta(6-16)](2) peptide comprising a dityrosine cross-link. This result demonstrates the presence of CL A beta dimers in the brains of patients with AD and opens up avenues for establishing new therapeutic targets and developing novel biomarkers for this disease.

AccesS level

Green Accepted

Mentions data

PAPER MENTIONS
Chemistry
  •   Twitter
  • 16
  •   Wikipedia
  • 0
  •   News
  • 7
  •   Policy
  • 0

Mentions Chart

Influratio by dimension
  • Twitter
  • Wikipedia
  • News
  • Policy
PAPER MENTIONS
  •   Twitter
  • 16
  •   Wikipedia
  • 0
  •   News
  • 7
  •   Policy
  • 0
PROYECTO FINANCIADO POR PLAN NACIONAL DE INVESTIGACIÓN AGENCIA ESTATAL DE INVESTIGACIÓN, MINISTERIO DE CIENCIA E INNOVACIÓN. PID2019-109127RB-I00